Connection
Debopam Samanta to Tuberous Sclerosis
This is a "connection" page, showing publications Debopam Samanta has written about Tuberous Sclerosis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
4.372 |
|
|
|
-
Samanta D. Evolving treatment strategies for early-life seizures in Tuberous Sclerosis Complex: A review and treatment algorithm. Epilepsy Behav. 2024 Dec; 161:110123.
Score: 0.889
-
Samanta D. Reply to comments on "A scoping review on cannabidiol therapy in tuberous sclerosis: Current evidence and perspectives for future development". Epilepsy Behav. 2022 06; 131(Pt A):108704.
Score: 0.747
-
Samanta D. A scoping review on cannabidiol therapy in tuberous sclerosis: Current evidence and perspectives for future development. Epilepsy Behav. 2022 03; 128:108577.
Score: 0.736
-
Samanta D. An Updated Review of Tuberous Sclerosis Complex-Associated Autism Spectrum Disorder. Pediatr Neurol. 2020 08; 109:4-11.
Score: 0.656
-
Samanta D. Acneiform Lesion: Importance of Detailed Skin Examination. Indian J Pediatr. 2016 May; 83(5):485-6.
Score: 0.477
-
Samanta D. Remarkable improvement of selective mutism with everolimus in a patient with tuberous sclerosis complex. Acta Neurol Belg. 2015 Dec; 115(4):815-7.
Score: 0.456
-
van Eeghen AM, Thiele EA, Amin S, Samanta D, Jansen AC, Stevens J, Moore-Ramdin L, de Vries PJ. Protocol for EpiCom: A phase 3b/4 study of behavioral outcomes following adjunctive cannabidiol for the management of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND). PLoS One. 2025; 20(6):e0324648.
Score: 0.232
-
Bajaj G, Lindberg MR, Chee W, Samanta D, Chhabra A. Fibroma-like PEComa: a newly recognized soft tissue neoplasm in tuberous sclerosis patients-imaging features and review of literature. Skeletal Radiol. 2022 Apr; 51(4):881-887.
Score: 0.179